• 1. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroquinolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolones and derivatives Hydroquinolones

Introduction to 6-Bromo-8-methyl-1,2-dihydroquinolin-2-one (CAS No. 99465-08-4) and Its Emerging Applications in Chemical Biology

6-Bromo-8-methyl-1,2-dihydroquinolin-2-one, identified by the CAS number 99465-08-4, is a heterocyclic compound that has garnered significant attention in the field of chemical biology due to its structural versatility and potential biological activities. This compound belongs to the quinoline derivatives family, a class of molecules well-known for their broad spectrum of pharmacological properties. The presence of both bromine and methyl substituents in its structure enhances its reactivity, making it a valuable scaffold for further chemical modifications and drug discovery initiatives.

The 1,2-dihydroquinolin-2-one core of this molecule is particularly noteworthy, as it serves as a privileged structure in medicinal chemistry. This scaffold has been extensively studied for its ability to interact with various biological targets, including enzymes and receptors. Recent advancements in computational chemistry and molecular modeling have highlighted the 6-Bromo-8-methyl-1,2-dihydroquinolin-2-one as a promising candidate for designing novel therapeutic agents. Its unique electronic distribution, influenced by the bromine atom's electronegativity and the methyl group's steric effects, allows for precise tuning of its binding affinity to biological macromolecules.

In the realm of drug discovery, the CAS No. 99465-08-4 compound has been employed in the development of inhibitors targeting key enzymes involved in metabolic pathways. For instance, studies have demonstrated its potential as a lead compound for inhibiting cyclin-dependent kinases (CDKs), which are critical regulators of cell cycle progression. The bromine substituent at the 6-position provides a handle for further derivatization via cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, enabling the introduction of diverse aryl or heteroaryl groups. This modularity has allowed researchers to generate libraries of analogs with tailored biological profiles.

Moreover, the 8-methyl group in the quinoline ring contributes to the compound's stability and solubility characteristics, which are essential factors in pharmaceutical development. The dihydroquinolinone moiety itself is known to exhibit significant bioisosteric properties with benzene rings, allowing it to fit into binding pockets of proteins with high precision. This feature has been exploited in designing molecules that mimic natural substrates or allosterically modulate enzyme activity. Recent publications have reported the synthesis of 6-Bromo-8-methyl-1,2-dihydroquinolin-2-one derivatives that show potent inhibition against kinases overexpressed in cancer cells, highlighting its therapeutic potential.

Recent research has also explored the antimicrobial properties of this compound. The bromine atom's presence can disrupt bacterial cell membranes by interfering with lipid synthesis or by acting as a hydrogen bond acceptor in essential bacterial enzymes. Preliminary studies have shown that certain derivatives of CAS No 99465-08-4 exhibit promising activity against Gram-positive bacteria, including strains resistant to conventional antibiotics. This finding is particularly relevant in light of the growing crisis of antibiotic resistance, where novel antimicrobial agents are urgently needed.

The synthesis of 6-Bromo-8-methyl-1,2-dihydroquinolin-2-one can be achieved through multiple pathways, each offering distinct advantages depending on the desired scale and purity requirements. One common approach involves the condensation of appropriately substituted acetic acid derivatives with ammonia or ammonium acetate under acidic conditions, followed by cyclization and bromination at the desired positions. Alternative methods include palladium-catalyzed cross-coupling reactions starting from halogenated precursors, which can be particularly useful for introducing complex aryl groups at specific positions on the quinoline scaffold.

In conclusion, 6-Bromo-8-methyl-1,2-dihydroquinolin-2-one (CAS No. 99465-08-4) represents a structurally intriguing molecule with significant potential in medicinal chemistry and chemical biology. Its unique combination of functional groups makes it an excellent platform for designing novel therapeutic agents targeting various diseases. As research continues to uncover new applications and synthetic strategies for this compound, it is poised to remain a cornerstone in future drug discovery efforts.

• 89446-19-5(6-Bromo-4-methylquinolin-2-ol)
• 54934-81-5(N-(4-bromophenyl)cinnamamide)
• 99465-10-8(7-bromo-1,2-dihydroquinolin-2-one)
• 67805-67-8(8-bromo-1,2-dihydroquinolin-2-one)
• 89446-45-7(2(1H)-Quinolinone, 6-bromo-4,8-dimethyl-)
• 1810-66-8(6-bromo-1,2-dihydroquinolin-2-one)
• 70254-42-1(2-Quinolinol)
• 67805-53-2(2(1H)-Quinolinone,8-bromo-1-methyl-(9CI))
• 104534-80-7(Quinolinone)
• 99465-09-5(5-Bromoquinolin-2(1H)-one)